U.S. Commercial Services Stock News

In its recent quarterly update, Ladder Capital Corp reported US$50.47 million in revenue, around a 26.4% year-on-year decline and below analyst expectations, alongside a miss on tangible book value per share estimates. This combination of weaker-than-expected revenue and tangible book value highlights pressure on both Ladder Capital’s income generation and balance-sheet performance versus peers. Next, we’ll examine how this earnings and tangible book value shortfall may affect Ladder...

On March 26, 2026, Oshkosh Corporation filed a definitive proxy statement urging shareholders to vote against a proposal that would require directors failing to win majority support in uncontested elections to leave the board within nine months, ahead of its May 5, 2026 annual meeting. This governance dispute coincides with improved geopolitical sentiment around tensions involving Iran, offering a fresh angle on Oshkosh’s risk profile and board accountability. Next, we’ll examine how the...

AT&T (T) just paired a stronger than expected quarter with the launch of OneConnect, a single subscription wireless and fiber bundle that targets billing simplicity, customer retention and broader device coverage across home and mobile use. See our latest analysis for AT&T. Those OneConnect headlines land at a time when momentum in AT&T’s shares has been rebuilding, with a 90 day share price return of 14.65% and a 1 year total shareholder return of 10.99%, even after some recent weekly...

Phibro Animal Health (PAHC) is back on investors’ radar after reporting earnings and revenue that surpassed expectations, supported by stronger vaccine sales and the integration of Zoetis’ MFA business, which is reinforcing interest in its animal health portfolio. See our latest analysis for Phibro Animal Health. The share price has reacted strongly to this run of positive updates, with a 30 day share price return of 15.9% and a 90 day share price return of 44.7%. This has contributed to a...

Q4 earnings beat on EPS puts American International Group (AIG) in focus American International Group (AIG) recently reported Q4 2025 earnings per share of US$1.96 on revenue of US$6.55b, topping EPS expectations while revenue came in below estimates and putting the stock on many investors' watchlists. See our latest analysis for American International Group. The Q4 surprise on earnings comes as AIG’s 7 day share price return of 3.39% contrasts with a 90 day share price decline of 10.62%. At...

HealthEquity, Inc. recently appointed William “Bill” Gassen, president and chief executive officer of Sanford Health, to its board of directors, adding him to the Audit and Risk Committee and the Talent, Compensation and Culture Committee effective March 26, 2026. This appointment brings deep rural health system and human capital expertise into the boardroom at a time when HealthEquity is expanding its AI-enabled, consumer-focused healthcare affordability platform. Next, we’ll examine how...

In late March 2026, Horace Mann Educators announced that Vice President, Controller and Chief Accounting Officer Maureen Temchuk began a temporary maternity leave, with Chief Financial Officer Ryan Greenier stepping in as Interim Chief Accounting Officer until her expected return in early July. This short-term leadership adjustment places the company’s financial reporting and accounting oversight directly under its CFO, potentially streamlining coordination between finance, investment, and...

Chipotle Mexican Grill (CMG) is back in focus after recent investor communications pointed to a potential business rebound in 2026, supported by new menu initiatives, evolving marketing and favorable analyst sentiment. See our latest analysis for Chipotle Mexican Grill. The recent optimism around a potential business rebound in 2026 comes after a choppy period, with a 1-day share price return of 1.62% and 7-day share price return of 7.45% alongside a 90-day share price return of 13.31% and a...

Hillman Solutions recently received reiterated positive analyst coverage following its first investor day and was honored with REDI Cincinnati’s James A. Wuenker Growth Award for its Forest Fair Mall Redevelopment Project, which consolidates multiple operations into a new multipurpose facility to enhance collaboration and efficiency. This combination of analyst confidence and recognition for an efficiency-focused redevelopment underscores how Hillman is actively reshaping its operational...

In early April 2026, research outlet The Bear Cave published a critical report alleging misleading billing practices, deceptive free trials, problematic cancellation processes, and misleading telemarketing at Yelp, arguing these issues could signal weaker customer relationships and revenue quality than the company presents. Separately, a recent SEC filing showed that Chief Product Officer Craig Saldanha sold 1,200 Yelp shares on April 1, 2026, contributing to a pattern of insider selling...

Alkami Technology (ALKT) is back on investor radar after activist hedge fund JANA Partners disclosed a 5.1% stake, describing the shares as undervalued, alongside new board appointments and fresh client momentum. See our latest analysis for Alkami Technology. Recent news around JANA Partners, new board appointments and client wins has come after a tougher spell for Alkami, with a 90 day share price return of a 30.04% decline, a year to date share price return of a 26.98% decline and a three...

Copa Holdings recently reported that analysts now expect double-digit year-over-year revenue growth for the upcoming quarter, even as earnings per share forecasts have been reduced by more than 15% ahead of its next results release. This combination of stronger sales expectations but weaker profit outlook, set against Copa’s role as a hub-focused Latin American carrier in the Russell 1000, raises fresh questions about the balance between growth and profitability in its business model. With...

Merck (MRK) is back in focus after two key milestones: strong Phase 3 data for its oral PCSK9 candidate enlicitide decanoate, and fresh EU approval expanding Keytruda’s ovarian cancer use. See our latest analysis for Merck. Merck’s share price has been firming over the past few months, with a 30 day share price return of 4.4% and a 90 day share price return of 12.5%. The 1 year total shareholder return of 53.8% reflects how investors have responded to ongoing trial updates, product approvals...

Envista Holdings recently expanded its manufacturing footprint with a new facility in Suzhou, China, and rolled out 2025 product launches including OptiBond 360, SimpliCore Composite, and CaviCide HP to better serve growing regional demand. This combination of increased local production capacity and a refreshed product portfolio highlights Envista’s emphasis on aligning innovation with geographic growth opportunities. We’ll now examine how the new Suzhou facility could influence Envista’s...

Core & Main (CNM) drew fresh attention after releasing fourth quarter and full year earnings, issuing new sales guidance, completing a share repurchase, and outlining board and leadership changes related to succession planning. See our latest analysis for Core & Main. The stock’s recent pattern has been mixed, with a 7-day share price return of 5.82% around earnings and governance news, set against a 90-day share price decline of 8.02%, while the 3-year total shareholder return of 131.59%...

In recent weeks, Adobe reported first-quarter fiscal 2026 results showing 12% revenue growth and higher non-GAAP operating profitability, while announcing long-serving CEO Shantanu Narayen’s planned retirement amid ongoing investment in generative AI across its product suite. At the same time, several Wall Street firms downgraded their ratings on Adobe, citing intensifying competition in Creative Cloud and questions about pricing power and AI execution, even as hedge funds increased...

Event context and recent price performance STAAR Surgical (STAA) has drawn investor attention after a recent move in its share price, with the stock up 4.6% over the past day and 12.9% over the past week. Over the past month, the stock shows a 9.5% gain, while the past 3 months reflect a 15.6% decline. This sets up a mixed recent performance profile for investors to assess. See our latest analysis for STAAR Surgical. At a share price of $20.21, STAAR Surgical’s recent gains sit against a...

Constellation Brands recently became the focus of diverging analyst views ahead of its 8 April 2026 fourth-quarter earnings release, with commentary highlighting softer organic growth, shipment pressures in key beer brands, and expectations for year-over-year declines in revenue and earnings. Investors are also watching the pending CEO transition and potentially more flexible longer-term guidance, as the company faces questions about sustaining beer strength while managing tariffs, weakening...

Recently, activist investor Land & Buildings raised its stake in Centerspace REIT to 9.19%, coinciding with Board Member Emily Nagle Green’s retirement and the declaration of a quarterly dividend. Taken together, the larger activist presence and board change may point to upcoming discussions around Centerspace’s capital allocation and portfolio direction. With Land & Buildings now owning over 9% of Centerspace, we’ll examine how this increased activist involvement could reshape its...

Citigroup (C) heads into its April 14 earnings report with heightened attention after multiple banks highlighted the stock, citing strong historical earnings surprises, segment reporting changes, and recast financial data as key short term catalysts. See our latest analysis for Citigroup. Recent headlines around preferred dividends, new bond issuance and senior hires come against a backdrop where Citigroup’s share price return has slipped 2.9% year to date, while it sits alongside a very...

Why Cheniere Energy (LNG) is on investors’ radar today Cheniere Energy (LNG) is drawing fresh attention after recent share price moves, with the stock showing mixed short term returns but strong gains over the past 3 months and year to date. See our latest analysis for Cheniere Energy. Recent trading has been choppy, with a 1 day share price return of 1.93% and a 7 day share price return of negative 5.30%. However, the 30 day share price return of 10.19% and 90 day share price return of...

What Costamare’s latest earnings and contracts mean for investors Costamare (CMRE) recently reported Q4 net income of about US$73 million and around US$370 million for the year, alongside US$590 million in liquidity and US$940 million of new forward-charter contracts across 12 vessels. Those contracts lift total contracted revenues to about US$3.4 billion with an average time charter duration of 4.5 years, and reported fleet employment of 96% for 2026 and 92% for 2027, giving investors...

On March 31, 2026, William Blair upgraded 10x Genomics from “Market Perform” to “Outperform,” citing its best-in-class genomics technology and improving execution. The upgrade highlighted a multinational Xenium-based spatial transcriptomics initiative targeting up to 100,000 patient tissue samples, underscoring 10x Genomics’ role in supplying AI-scale biological datasets. Next, we’ll examine how this AI-focused spatial data initiative may reshape 10x Genomics’ investment narrative and...

In late March and early April 2026, Toll Brothers announced a series of new and expanding luxury communities across the US, including high-end townhomes in Charlotte, waterfront residences in Marion, Massachusetts, and a new phase at Monterey at Lakewood Ranch in Florida, alongside the appointment of Karl K. Mistry to its Board. These moves highlight the company’s continued focus on affluent buyers and geographically diverse product expansion, adding new communities in North Carolina,...